Viewing Study NCT07178795


Ignite Creation Date: 2025-12-24 @ 2:08 PM
Ignite Modification Date: 2025-12-29 @ 1:22 PM
Study NCT ID: NCT07178795
Status: RECRUITING
Last Update Posted: 2025-11-17
First Post: 2025-09-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of HER2-mutant Advanced or Metastatic Non-squamous NSCLC
Sponsor:
Organization: